Drug trial targets early warning signs of blood cancer
NCT ID NCT05102370
Summary
This small, early-stage study tested whether a drug called enasidenib could safely improve low blood cell counts in people with a condition called CCUS. CCUS involves abnormal blood cells and low counts but is not yet cancer, though it can increase the risk of developing blood cancers. Researchers wanted to see if blocking a specific mutated protein with this drug could help patients' blood counts recover.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic (Data Collection Only)
Cleveland, Ohio, 44195, United States
-
Mayo Clinic (Data Collection Only)
Rochester, Minnesota, 55905, United States
-
Memorial Sloan Kettering Bergen (Limited protocol activities)
Montvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065, United States
-
Memorial Sloan Kettering Monmouth (All protocol activities)
Middletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Nassau (Limited protocol activities)
Rockville Centre, New York, 11553, United States
-
Memorial Sloan Kettering Suffolk-Commack (Limited protocol activities)
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York, 10604, United States
-
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey, 07920, United States
-
Ohio State University (Data Collection Only)
Columbus, Ohio, 43210, United States
-
Oregon Health & Science University (Data Collection Only)
Portland, Oregon, 97239, United States
-
Washington University (Data Collection and Specimen Analysis)
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.